SCNI
Scinai Immunotherapeutics
SCNI
SCNI
8 hedge funds and large institutions have $3.12M invested in Scinai Immunotherapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $4.43M → $3.12M (-$1.31M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
8
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$53.1K | |
| 2 | +$20.1K | |
| 3 | +$16.2K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1K |
Top Sellers
| 1 | -$525K | |
| 2 | -$232K | |
| 3 | -$13.9K | |
| 4 |
Morgan Stanley
New York
|
-$5K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |